INS and metabolic disease: Skeletal muscles account for 60%–70% of the insulin-stimulated glucose uptake and are described as a primary determinant of metabolic disorders (Turpin et al., 2009; Montgomery et al., 2017; Mikovic and Lamon, 2018).